![]() |
市場調查報告書
商品編碼
2028311
全髖置換術市場規模、佔有率、成長及全球產業分析:按類型、應用和地區分類的洞察,2026-2034 年預測Hip Replacement Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受骨關節炎盛行率上升和人口快速老化的影響,全球髖關節置換市場正穩定成長。 2025年,該市場規模為84億美元,預計2026年將成長至88億美元,到2034年將達到137.6億美元。北美地區憑藉著完善的醫療基礎設施和有利的報銷政策,在2025年佔市場主導地位,市佔率達34.46%。
全髖關節置換術(也稱為髖關節成形術)是一種外科手術,透過植入人工植入來取代受損的髖關節,恢復活動能力並減輕疼痛。關節相關疾病負擔的日益加重以及人們對先進治療方法的認知不斷提高,是推動該市場擴張的主要因素。
市場趨勢
影響市場的關鍵趨勢之一是人們對全髖關節置換術及術後護理的認知度不斷提高。患者擴大使用數位平台和行動應用程式來獲取復健指導並與醫療專業人員溝通。數位化工具的應用正在改善患者的治療效果,並增強他們對手術的信心。
此外,機器人輔助手術的應用正日益普及。先進的機器人系統能夠提高手術精度、縮短恢復時間並改善植入放置效果。這些技術日益廣泛的應用正在改變傳統的整形外科手術,並推動市場創新。
市場促進因素
骨關節炎盛行率的不斷上升是髖關節置換市場的主要促進因素。全球健康數據顯示,55歲以上人口中約有70%患有骨關節炎,顯著增加了對人工髖關節的需求。這種疾病會導致嚴重的關節損傷和疼痛,在晚期就需要進行手術介入。
另一個主要促進因素是全球人口老化。老年人更容易患關節疾病,促使髖關節置換術增加。此外,醫療保健服務的可近性提高以及有利的保險報銷機制,尤其是在已開發國家,也鼓勵患者接受手術。例如,在美國,大多數髖關節置換術都包含在主要醫療保險計劃的承保範圍內,從而提高了患者獲得治療的機會。
對客製化人工髖關節的需求也是推動市場成長的因素之一。 3D列印技術的應用使得為每位患者量身定做植入成為可能,從而改善手術效果並提高植入的耐用性。
市場限制因素
儘管預計市場將保持強勁成長,但產品召回和法律問題仍是該市場面臨的挑戰。缺陷植入可能導致感染疾病、過敏反應和金屬中毒等併發症。這些問題已導致針對主要製造商的多起訴訟,影響了市場信心。
此外,人工髖關節置換術和植入的高成本可能限制其在低收入和中等收入國家的普及。對熟練外科醫生和先進醫療基礎設施的需求進一步限制了發展中地區的市場成長。
就手術方法而言,全髖關節置換術術佔市場主導地位,預計到 2026 年將佔 73.86% 的市場佔有率。這種主導地位歸功於全球範圍內全髖關節置換術數量的高以及機器人輔助手術的日益普及。
此外,由於矯正手術的需求不斷成長以及植入技術的進步,部分髖關節置換術和重新置換術也呈現成長趨勢。
以最終用戶分類,醫院和門診手術中心(ASC)佔最大佔有率,預計到2026年將達到72.96%。這主要得益於手術數量的增加和先進醫療設施的普及。由於尋求關節相關疾病治療的患者人數不斷成長,整形外科診所也在穩步發展。
預計北美將在2025年以29億美元的市場規模引領全球,並在2026年達到30.4億美元,這主要得益於其龐大的手術量和健全的保險報銷體系。美國憑藉其先進的醫療基礎設施和技術創新,仍然是最大的市場貢獻者。
預計到2025年,歐洲的髖關節置換市場規模將達到21.8億美元,到2026年將達到22.7億美元,主要得益於高手術量和有利的醫療政策。德國等國家每年進行近20萬例髖置換術,凸顯了該地區強勁的需求。
亞太地區正崛起為高成長地區,預計2025年將達到19.2億美元,2026年將達到20.3億美元,主要得益於醫療基礎設施的改善和公眾健康意識的提高。拉丁美洲和中東及非洲地區預計將呈現溫和成長,這主要是由於疾病流行率上升和醫療投資增加所致。
The global hip replacement market is experiencing steady growth driven by the increasing prevalence of osteoarthritis and a rapidly aging population. The market was valued at USD 8.40 billion in 2025, grew to USD 8.80 billion in 2026, and is projected to reach USD 13.76 billion by 2034. North America dominated the market with a 34.46% share in 2025, supported by strong healthcare infrastructure and favorable reimbursement policies.
Hip replacement, also known as hip arthroplasty, is a surgical procedure that replaces damaged hip joints with artificial implants to restore mobility and reduce pain. The growing burden of joint-related disorders and increasing awareness about advanced treatment options are significantly contributing to market expansion.
Market Trends
One of the key trends shaping the market is the increasing awareness of hip replacement procedures and post-operative care. Patients are increasingly relying on digital platforms and mobile applications for recovery guidance and communication with healthcare providers. The integration of digital tools is improving patient outcomes and boosting confidence in surgical procedures.
Additionally, the adoption of robotic-assisted surgeries is gaining momentum. Advanced robotic systems enhance surgical precision, reduce recovery time, and improve implant positioning. The growing use of such technologies is transforming traditional orthopedic procedures and driving innovation in the market.
Market Drivers
The rising prevalence of osteoarthritis is a major driver of the hip replacement market. According to global health data, nearly 70% of individuals aged above 55 years are affected by osteoarthritis, significantly increasing the demand for hip implants. The condition leads to severe joint damage and pain, necessitating surgical intervention in advanced stages.
Another key driver is the growing geriatric population worldwide. Aging individuals are more prone to joint disorders, increasing the number of hip replacement procedures. Furthermore, improved healthcare access and favorable reimbursement policies, especially in developed countries, are encouraging patients to undergo surgeries. For instance, most hip replacement procedures are covered under major healthcare plans in the U.S., enhancing treatment accessibility.
The demand for customized hip implants is also contributing to market growth. The use of 3D printing technology enables the development of patient-specific implants, improving surgical outcomes and implant longevity.
Market Restraints
Despite strong growth prospects, the market faces challenges related to product recalls and legal issues. Defective implants can lead to complications such as infections, allergic reactions, and metal toxicity. These issues have resulted in numerous lawsuits against major manufacturers, impacting market confidence.
Additionally, the high cost of hip replacement procedures and implants can limit adoption in low- and middle-income countries. The need for skilled surgeons and advanced healthcare infrastructure further restricts market growth in developing regions.
By procedure, the total hip replacement segment dominates the market, accounting for 73.86% share in 2026. This dominance is attributed to the high number of total hip arthroplasty procedures performed globally and the increasing adoption of robotic-assisted surgeries.
Partial hip replacement and revision procedures are also witnessing growth due to the rising need for corrective surgeries and improved implant technologies.
By end-user, hospitals and ambulatory surgery centers (ASCs) hold the largest share, accounting for 72.96% in 2026, driven by the increasing number of surgical procedures and availability of advanced medical facilities. Orthopedic clinics are also growing steadily due to rising patient visits for joint-related treatments.
North America leads the market with USD 2.9 billion in 2025 and is projected to reach USD 3.04 billion in 2026, driven by high procedure volumes and strong reimbursement systems. The U.S. remains the largest contributor due to advanced healthcare infrastructure and technological innovation.
Europe accounted for USD 2.18 billion in 2025 and is expected to reach USD 2.27 billion in 2026, supported by a high number of surgeries and favorable healthcare policies. Countries such as Germany perform nearly 200,000 hip replacement surgeries annually, highlighting strong regional demand.
Asia Pacific is emerging as a high-growth region, valued at USD 1.92 billion in 2025 and projected to reach USD 2.03 billion in 2026, driven by improving healthcare infrastructure and increasing awareness. Latin America and the Middle East & Africa are witnessing moderate growth due to rising disease prevalence and healthcare investments.
Competitive Landscape
The market is highly competitive, with key players such as Zimmer Biomet, DePuy Synthes, and Stryker holding a significant share. These companies focus on product innovation, strategic collaborations, and expansion of distribution networks.
Recent developments include the introduction of robotic-assisted systems and advanced implant technologies. Companies are also investing in augmented reality and navigation systems to enhance surgical precision and outcomes.
Conclusion
The hip replacement market is projected to grow from USD 8.40 billion in 2025 to USD 13.76 billion by 2034, driven by the rising prevalence of osteoarthritis, increasing geriatric population, and advancements in surgical technologies. While challenges such as high costs and product recalls persist, ongoing innovations and expanding healthcare access are expected to support sustained long-term market growth.
Segmentation By Procedure
By End-user
By Geography